Advanced search
Publication Cover
OncoImmunology Volume 12, 2023 - Issue 1
Submit an article Journal homepage
497
Views
0
CrossRef citations to date
0
Altmetric
Author’s View

Interleukin-27 tackles immunosuppression in chronic lymphocytic leukemia

Iria Fernandez Botanaa Tumor Stroma Interactions, Department of Cancer Research, Luxembourg Institute of Health, Luxembourg;b Faculty of Science, Technology and Medicine, University of Luxembourg, Esch-sur-Alzette, LuxembourgView further author information
,
Giulia Paganoa Tumor Stroma Interactions, Department of Cancer Research, Luxembourg Institute of Health, Luxembourg;b Faculty of Science, Technology and Medicine, University of Luxembourg, Esch-sur-Alzette, LuxembourgView further author information
,
Etienne Moussaya Tumor Stroma Interactions, Department of Cancer Research, Luxembourg Institute of Health, LuxembourgCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-0879-8067View further author information
ORCID Icon &
Jerome Paggettia Tumor Stroma Interactions, Department of Cancer Research, Luxembourg Institute of Health, LuxembourgCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0001-9460-5876View further author information
ORCID Icon
Article: 2276490 | Received 20 Oct 2023, Accepted 24 Oct 2023, Published online: 03 Nov 2023

References

  • Conlon KC, Miljkovic MD, Waldmann TA. Cytokines in the treatment of cancer. J Interferon Cytokine Res. 2019;39(1):6–3. doi:10.1089/jir.2018.0019.
  • Fabbi M, Carbotti G, Ferrini S. Dual roles of IL-27 in cancer biology and immunotherapy. Mediators Inflamm. 2017;2017:3958069. doi:10.1155/2017/3958069.
  • Svanberg R, Janum S, Patten PE, Ramsay AG, Niemann CU. Targeting the tumor microenvironment in chronic lymphocytic leukemia. Haematologica. 2021;106(9):2312–2324. doi:10.3324/haematol.2020.268037.
  • Wierz M, Janji B, Berchem G, Moussay E, Paggetti J High-dimensional mass cytometry analysis revealed microenvironment complexity in chronic lymphocytic leukemia. Oncoimmunology. 2018;7(8):e1465167. doi:10.1080/2162402X.2018.1465167.
  • Wierz M, Pierson S, Guyonnet L, Viry E, Lequeux A, Oudin A, Niclou SP, Ollert M, Berchem G, Janji B, Guérin C. Dual PD1/LAG3 immune checkpoint blockade limits tumor development in a murine model of chronic lymphocytic leukemia. Blood. 2018;131(14):1617–1621. doi:10.1182/blood-2017-06-792267.
  • Cid LL, Leong JK, Botana IF, Paul Y, Wierz M, Floerchinger A, Gonder S, Pagano G, Chazotte M, Bestak K, Schifflers CT. High-dimensional single-cell definition of CLL T cells identifies galectin-9 as novel immunotherapy target. bioRxiv. 2022. doi:10.1101/2022.12.15.519719.
  • Mantovani A, Allavena P., Sica A., Balkwill F. Cancer-related inflammation. Nature. 2008;454(7203):436–444. doi:10.1038/nature07205.
  • Pagano G, Botana IF, Wierz M, Roessner PM, Ioannou N, Zhou X, Al-Hity G, Borne C, Gargiulo E, Gonder S, Qu B. Interleukin-27 potentiates CD8+ T-cell-mediated anti-tumor immunity in chronic lymphocytic leukemia. Haematologica. 2023. doi:10.3324/haematol.2022.282474.
  • Zorzoli A, Di Carlo E, Cocco C, Ognio E, Ribatti D, Ferretti E, Dufour C, Locatelli F, Montagna D, Airoldi I, et al. Interleukin-27 inhibits the growth of pediatric acute myeloid leukemia in NOD/SCID/Il2rg−/− mice. Clin Cancer Res. 2012;18(6):1630–1640. doi:10.1158/1078-0432.CCR-11-2432.
  • Schoppmeyer R, Zhao R, Cheng H, Hamed M, Liu C, Zhou X, Schwarz EC, Zhou Y, Knörck A, Schwär G, et al. Human profilin 1 is a negative regulator of CTL mediated cell-killing and migration. Eur J Immunol. 2017;47(9):1562–1572. doi:10.1002/eji.201747124.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.